兼任主治醫師：黃莉棋

論文及學術著作

1. Ching-Ling Lin, Ming-Lin Tsai, Chun-Yu Lin, Kai-Wen Hsu, Wen-Shyang Hsieh, Wei-Ming Chi, Li-Chi Huang and Chia-Hwa Lee, HDAC1 and HDAC2 Double Knock-out Triggers Cell Apoptosis in Advanced Thyroid Cancer.. International Journal of Molecular Sciences. 2019, 20(2), 454
2. Ruey-Yu Chen , Li-Chi Huang , Chien-Tien Su, Yao-Tsung Chang , Chia-Lin Chu, Chiao-Ling Chang, Ching-Ling Lin, Effectiveness of Short-Term Health Coaching on Diabetes Control and Self-Management Efficacy: A Quasi-Experimental Trial. Front Public Health. 2019 Oct 30;7:314.
3. Li-Chi Huang, Winnie Liu, Chun-Yu Lin, Kai-Wen Hsu, Ka-Wai Tam, Wen-Shyang Hsieh, Wei-Ming Chi, Jinn-Moon Yang, *Ching-Ling Lin and Chia-Hwa Lee. “CRISPR/Cas9 genome editing of Epidermal Growth Factor Receptor sufficiently abolished oncogenicity in Anaplastic Thyroid cancer.” Disease Markers. 2018, 1-14.
4. Kai-Wen Hsu, Chien-Yu Huang, Ka-Wai Tam, Chun-Yu Lin, Li-Chi Huang, Ching-Ling Lin, Wen-Shyang Hsieh, Wei-Ming Chi, Yu-Jia Chang, Po-Li Wei, Shou Tung Chen and Chia-Hwa Lee. 2018. “The application of Non-Invasive Apoptosis Detection Sensor (NIADS) on Histone Deacetylation Inhibitors (HDACi) Induced Breast Cancer Cell Death.” International Journal of Molecular Sciences. 19, 452;
5. Li-Chi Huang, Ching-Ling Lin*, Jia-Zheng Qiu, Chun-Yu Lin, Kai-Wen Hsu, Ka-Wai Tam, Jung-Yu Lee, Jinn-Moon Yang and Chia-Hwa Lee. 2017. “Nicotinic Acetylcholine Receptor Subtype Alpha-9 Mediates Triple-Negative Breast Cancers Based on a Spontaneous Pulmonary Metastasis Mouse Model.” Frontiers in Cellular Neuroscience. 11:336.
6. Li-chi Huang, Ruey-Yu Chen, Yao-Tsung Chang, Chien-Tien Su, Ching-Ling Lin. Benefits of Health Coaching on Improving Chronic Care for Patients with Type 2 Diabetes Mellitus. Formosan Journal of Endocrinology and Metabolism. Jun 2017, Vol.8, No 1.
7. Shih-Hsin Tu, Yi-Chen Hsieh, Li-Chi Huang, Chun-Yu Lin, Kai-Wen Hsu, Wen-Shyang Hsieh, Wei-Ming Chi and Chia-Hwa Lee. 2017. “A Rapid and Quantitative Method to Detect Human Circulating Tumor Cells in a Preclinical Animal Model.” BMC CANCER. 17(1), pp. 440.